Against a backdrop of increased demand related to AI and power infrastructure, the FY2026 Q2 results showed a substantial increase in operating profit and an upward revision to the full-year forecast on a cumulative basis. Key drivers were the reflection of the DPE suspension impact and inventory effects. Life Innovation was affected by reduced shipments of rapid antigen test kits, but the overall company revised guidance upward. Dividend is expected to be maintained at 100 yen per share.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4061","jir_company_name":"Denka Company Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4061-20261109-02.pdf","jir_short_summary":"Against a backdrop of increased demand related to AI and power infrastructure, the FY2026 Q2 results showed a substantial increase in operating profit and an upward revision to the full-year forecast on a cumulative basis. Key drivers were the reflection of the DPE suspension impact and inventory effects. Life Innovation was affected by reduced shipments of rapid antigen test kits, but the overall company revised guidance upward. Dividend is expected to be maintained at 100 yen per share.","jir_summary":"### Summary of Results\nConsolidated results for FY2026 Q2 were revenue of 2,087 hundred million yen (Year-over-Year +408 hundred million yen), operating income of 247 hundred million yen (Year-over-Year +150 hundred million yen), and net income attributable to owners of parent of 69 hundred million yen (Year-over-Year +30 hundred million yen), securing a substantial increase in profitability. Expansion of demand related to AI and power infrastructure and the effect of DPE operational suspension contributed. There was an adjustment in shipments of rapid antigen diagnostic kits, but on a company-wide basis guidance was revised upward.\n\n### Outlook and Dividend\nFull-year earnings forecasts for FY2026 are expected to be revised upward, reflecting continued demand for AI-related and power infrastructure applications and the net contribution from inventory effects. As for dividend policy, while targeting a total shareholder return ratio of about 56%, the dividend per share will be maintained. A management briefing is scheduled for December.","jir_financial_highlights":"Revenue: 2,087 (Year-over-Year +408)\nOperating Income: 247 (Year-over-Year +150)\nNet Income Attributable to Owners of Parent: 69 (Year-over-Year +30)","jir_category":"","jir_hashtags":"#Denka, #Earnings, #AI_related, #Power_Infrastructure","jir_key_figures":"Revenue: 2,087 hundred million yen (FY2026 H1 results)\nOperating Income: 247 hundred million yen (FY2026 H1 results)\nNet Income Attributable to Owners of Parent: 69 hundred million yen (FY2026 H1 results)","jir_meta_title":"Denka Company Limited FY2026 Q2 Financial Summary | Profit Growth Supported by AI and Power Infrastructure Demand","jir_meta_description":"Denka Company Limited FY2026 Q2 financial summary: revenue 2,087 hundred million yen, operating income 247 hundred million yen, net income 69 hundred million yen. Growth driven by AI-related and power infrastructure demand, with an upward revision to full-year forecast. Dividend policy maintains 100 yen per share.","jir_og_title":"Denka Company Limited FY2026 Q2 Financial Summary | AI-related Demand Boosts Profit","jir_og_description":"Q2 results: revenue 2,087 hundred million yen; operating income 247 hundred million yen; net income 69 hundred million yen. Expansion in AI-related and power infrastructure demand and inventory effects contributed. Dividend expected to be maintained at 100 yen per share.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Margin Analysis\", \"jir_chart_json_data\": \"\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Forecast vs Actual Comparison\", \"jir_chart_json_data\": \"\"}]","ir_related_company":8858,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-144355","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n